Unless they have discovered a new shiney molecule that is worthy of funding....
As shareholders I reckon most would want the company to ask us to fund it, if it has real potential and so long as it didn't distract from bringing Bisantrene to market....
RAC Price at posting:
$1.47 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)